Published 2004 | Version v1
Publication

Cytogenetic and fluorescence in situ hybridization monitoring in Ph+ chronic myeloid leukemia patients treated with Imatinib mesylate.

Additional details

Created:
March 27, 2023
Modified:
November 29, 2023